Equity markets around the globe have been under pressure on account of trade war fears, interest rate hike and valuation concerns
Mehta Equities is bullish on Omkar Speciality chemicals (OSCL) and has recommended buy rating on the stock with a target price of Rs 140 in its June, 2013 research report.
Omkar Speciality can test Rs 180-200 in next six to eight months, says Aashish Tater, Head of Research, Fortunewizard.com.
In an interview with CNBC-TV18, Pravin Shivdas Harlekar, MD, Omkar Speciality said the company’s existing capacity is 950 metric tonne. “By FY13, we would like to expand up to 3,650 metric tonne per year,” he added.
In an interview with CNBC-TV18, Pravin Shivdas Harlekar, MD, Omkar Speciality says, the company is targeting atleast 45% revenue growth in FY12.
In an exclusive interview with CNBC-TV18’s Soniya Shenoy and Ekta Batra, Pravin Shivdas Harlekar, Chairman and Managing Director of Omkar Speciality says that the company is confident of a 45% growth in revenues in FY11. “The target is to cross Rs 150 crore in 2011-12,” he says.